Coordinating Center for Research Centers for Improving Management of Symptoms During and Following Cancer Treatment

改善癌症治疗期间和治疗后症状管理研究中心协调中心

• 批准号: 10833736
• 负责人: Mary-Anne Ardini
• 金额: $ 45.1万
• 依托单位: RESEARCH TRIANGLE INSTITUTE
• 依托单位国家: 美国
• 财政年份: 2023
• 资助国家: 美国
• 起止时间: 2023-05-01 至 2024-08-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10833736
• 关键词: Acceleration; Address; Administrative Supplement; Adoption; Archives; Award; Cancer Patient; Cancer Survivorship; Collaborations; Communication; Communication Tools; Communities; Continuity of Patient Care; Custom; Data; Data Aggregation; Data Set; Development; Documentation; Education; Electronic Health Record; Ensure; Fostering; Frequencies; Goals; International; Intervention; Lead; Leadership; Malignant Neoplasms; Manuscripts; Maps; Methods; Minority; Monitor; Patients; Process; Productivity; Publications; Quality of life; Recommendation; Reporting; Research; Research Personnel; Running; Schedule; Site; Symptoms; System; Work; anticancer research; cancer care; cancer therapy; common treatment; data harmonization; data modeling; data sharing; data standards; effectiveness outcome; evidence base; implementation evaluation; implementation outcomes; improved; medically underserved population; meetings; palliative; preservation; side effect; success; symposium; symptom management; symptomatic improvement; treatment research; web site; web-based tool

Project Summary To advance the Beau Biden Cancer MoonshotSM Initiative to accelerate cancer research and the Blue Ribbon Panel’s recommendation to minimize cancer treatment’s debilitating side effects, RTI International will continue to serve as the Coordinating Center (CC) for the Research Centers (RCs) for Improving Management of Symptoms Across Cancer Treatments (IMPACT) Consortium. As the CC, RTI will provide leadership, scientific expertise, and logistical support to the consortium projects that seek to improve symptom management across the cancer treatment continuum (i.e., treatment with curative intent, treatment with noncurative/palliative intent, cancer survivorship) and address the unique challenges of minority and medically underserved populations. Specifically, we will enhance research efficiency, productivity, and impact by facilitating collaboration and providing the logistical, communications, and operational support necessary to run a multicenter research Consortium; facilitate the development of evidence-based symptom management recommendations based on results across studies and research sites; and accelerate adoption of integrated systems for monitoring and managing patient-reported symptoms by collaborating with RCs to broadly disseminate findings. This application has specific strengths that will enhance the scientific productivity of the Consortium. The CC will foster collaboration within the IMPACT Consortium by uniting diverse researchers around shared goals and harmonized studies. RTI will promote effective communication by developing and maintaining custom web- based tools for communications and document sharing. RTI will leverage data standards and harmonization across the Consortium to catalyze data sharing and aggregation.

项目摘要 推进博拜登癌症登月SM倡议，加速癌症研究和蓝丝带 专家小组建议将癌症治疗的破坏性副作用降至最低，国际RTI将继续 担任研究中心(RCS)的协调中心(CC)，以改善对 癌症治疗中的症状(IMPACT)联盟。作为CC，RTI将提供领导、科学 向寻求改善症状管理的财团项目提供专业知识和后勤支持 癌症治疗连续体(即，有根治意图的治疗，无根治/姑息意图的治疗， 癌症存活期)，并解决少数群体和医疗服务不足人群的独特挑战。 具体地说，我们将通过促进合作和 提供运行多中心研究所需的后勤、通信和运营支持 联合会；促进基于证据的症状管理建议的制定 跨研究和研究地点的结果；并加快采用集成系统进行监测和 通过与RCS合作广泛传播研究结果来管理患者报告的症状。这 应用程序具有特定的优势，将提高联盟的科学生产率。消委会将 通过将不同的研究人员团结在共同的目标和 协调研究。RTI将通过开发和维护定制网络来促进有效的沟通- 基于通信和文档共享的工具。RTI将利用数据标准和协调 以促进数据共享和聚合。